Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 27Mesothelioma, Malignant 14Solid Tumors 11Mesothelioma 10Advanced Solid Tumor 8Solid Tumor 5Advanced Solid Tumors 4Carcinoma, Non-Small-Cell Lung 3Solitary Fibrous Tumor, Pleural 2Uterine Cervical Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Penile Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Metastatic Solid Tumors 1Malignant Neoplasmas 1Lung Neoplasms 1Locally Advanced or Metastatic Solid Tumours 1Cholangiocarcinoma of the Gallbladder 1Advanced Solid Tumours 1Advanced Solid Tumour 1Advanced Cancer 1Advance Solid Tumors 1Adult Solid Tumor 1

Interventions

ON 01910 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Neoplasmas × Gemcitabine × Other solid neoplasm × Clear all
NCT01125891 2017-06-23

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

Traws Pharma, Inc.

Phase 1 Completed
39 enrolled
Other neoplasmOther solid neoplasm

Malignant Neoplasmas

Data powered by HemOnc (CC BY 4.0) Colophon âš¡